低流速低梯度重度主动脉瓣狭窄伴保留射血分数患者对硝普钠的血流动力学反应
结果显示硝普钠降低后负荷和左室充盈压,使25%患者主动脉瓣面积增至≥1.0 cm²而重新分类为中度狭窄,低流速患者对后负荷降低的敏感性更高。
要点
- 硝普钠可降低低梯度重度主动脉瓣狭窄患者的后负荷和左室充盈压。
- 约25%患者用药后瓣口面积增至≥1.0 cm²,可重新分类为中度狭窄。
- 低流速患者基线动脉顺应性更低、有效动脉弹性更高,对后负荷降低更敏感。
核心结论
- 硝普钠降低低梯度重度主动脉瓣狭窄伴保留射血分数患者的后负荷和左室充盈压,使25%患者重新分类为中度狭窄。
- 基线每搏输出量指数与后负荷降低后每搏输出量指数变化呈负相关,提示低流速患者对后负荷高度敏感。
研究设计与样本
- 症状性低梯度重度主动脉瓣狭窄且射血分数保留的患者接受心脏导管检查,比较硝普钠使用前后的血流动力学测量。
主要发现
- 基线时低流速患者总动脉顺应性更低(0.36 ± 0.12 ml/m²/mm Hg vs. 0.48 ± 0.16 ml/m²/mm Hg;p = 0.01)。
- 基线时低流速患者有效动脉弹性更高(2.77 ± 0.84 mm Hg·m²/ml vs. 1.89 ± 0.82 mm Hg·m²/ml;p = 0.002)。
- 所有患者使用硝普钠后弹性、左室充盈压和肺动脉压均降低,顺应性改善(p < 0.05)。
- 低流速患者中6例(24%)、正常流速患者中4例(25%)主动脉瓣面积增至≥1.0 cm²。
- 低流速患者每搏输出量指数改善(3 ± 6 ml/m²;p = 0.02)。
临床怎么用
- 对低梯度重度主动脉瓣狭窄伴保留射血分数患者,可考虑用硝普钠行血流动力学评估以鉴别真性重度狭窄。
- 后负荷降低后约四分之一患者可重新分类为中度狭窄,可能影响治疗决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low-gradient severe aortic stenosis (LGSAS) with preserved ejection fraction (EF) is incompletely understood. The influence of arterial afterload and diastolic dysfunction on the hemodynamic presentation of LGSAS remains unknown. OBJECTIVES: The authors sought to determine the acute hemodynamic response to sodium nitroprusside in LGSAS with preserved EF. METHODS: Symptomatic patients with LGSAS and preserved EF underwent cardiac catheterization with comparison of hemodynamic measurements before and after nitroprusside. RESULTS: Forty-one subjects (25 with low flow [LF], stroke volume index [SVI] ≤35 ml/m2, 16 with normal flow [NF]) were included. At baseline, LF patients had lower total arterial compliance (0.36 ± 0.12 ml/m2/mm Hg vs. 0.48 ± 0.16 ml/m2/mm Hg; p = 0.01) and greater effective arterial elastance (2.77 ± 0.84 mm Hg · m2/ml vs. 1.89 ± 0.82 mm Hg · m2/ml; p = 0.002). In all patients, nitroprusside reduced elastance, left ventricular filling pressures, and pulmonary artery pressures and improved compliance (p < 0.05). Aortic valve area increased to ≥1.0 cm2 in 6 LF (24%) and 4 NF (25%) subjects. Change in SVI with nitroprusside varied inversely to baseline SVI and demonstrated improvement in LF only (3 ± 6 ml/m2; p = 0.02). CONCLUSIONS: Nitroprusside reduces afterload and left ventricular filling pressures in patients with LGSAS and preserved EF, enabling reclassification to moderate stenosis in 25% of patients. An inverse relationship between baseline SVI and change in SVI with afterload reduction was observed, suggesting that heightened sensitivity to afterload is a significant contributor to LF-LGSAS pathophysiology. These data highlight the utility of afterload reduction in the diagnostic assessment of LGSAS.
引用
- Lloyd JW, Nishimura RA, Borlaug BA, et al. Hemodynamic Response to Nitroprusside in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Ejection Fraction. J Am Coll Cardiol. 2017. PMID: 28882231. doi:10.1016/j.jacc.2017.07.736
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。